Patentability and Intellectual Property Issues Related to Chitosan-Based Biopharmaceutical Products

Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics

Volumn , Issue , 2012, Pages 483-502

  Videira, Mafalda ^a   Gaspar, Rogério ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Chinese growth rates for chitosan based applications, impressive; Chitosan as a pharmaceutical excipient, depending on nature of chitosan; Chitosan based nanoparticle formulations and patents, ES 2098188 patent; Chitosan based ocular therapy; Gene expression and siRNA, and gene expression deregulation; Nanomedicines, repercussions in future of life sciences; Patentability and intellectual property issues, on chitosan based products; Recent trends, using chitosan in gene therapy; Role of chitosan as a pharmaceutical excipient; Tissue engineering and wound management

Indexed keywords

EID: 84885532304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119962977.ch25     Document Type: Chapter

References (150)

1. Illum, L. (1998) Chitosan and its uses as a pharmaceutical excipient. Pharm. Res., 15, 1326-1331.
2. Rigby, G.W. (1936) Substantially undegraded deacetylated chitin and process for producing the same, Patent US 2040879.
3. Peniston, Q.P. and Johnson, E.L. (1980) Process for the manufacture of chitosan, Patent US 4195175.
4. Mukherjee, D.P. (2001) Method for producing chitin or chitosan, Patent US 6310188.
5. Muzzarelli, R.A. (2009) Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr. Polym., 76, 167-182.
6. Pittler, M.H. and Ernst, E. (2004) Dietary supplements for body-weight reduction: a systematic review. Am. J. Clin. Nutr., 79, 529-536.
7. Ravi Kumar, M.N.V. (2000) A review of chitin and chitosan applications. React. Funct. Polym., 46, 1-27.
8. Dutta, P.K., Dutta, J. and Tripathi, V.S. (2004) Chitin and chitosan: chemistry, properties and applications. J. Sci. Ind. Res., 63, 20-31.
9. Lopez-Leon, T., Carvalho, E.L., Seijo, B. et al. (2005) Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J. Colloid Interface Sci., 283, 344-351.
10. Muzzarelli, R.A.A. and Muzzarelli, C. (2005) Chitin nanofibrils, in Chitin and Chitosan: Research Opportunities and Challenges (ed P.K. Dutta), New Age International, New Delhi, India.
11. Wang, Z., Hu, Q. and Cai, L. (2010) Chitin fiber and chitosan 3D composite rods. Int. J. Polym. Sci., 2010, 1-7.
12. Felt, O., Buri, P. and Gurny, R. (1998) Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm., 24, 979-993.
13. Davison, G.R., Konig, A., Gibbons, C. et al. (2003) Chitosan compositions, Patent WO 03042251.
14. Knapczyk, J. (1993) Excipient ability of chitosan for direct tableting. Int. J. Pharm., 89, 1-7.
15. Lang, G.,Wendel, H. and Konrad, E. (1988) Quaternary hydroxy-propyl-substituted chitosan derivatives, cosmetic compositions based thereon and processes for the production thereof, Patent US 4772689.
16. Kumar, M.N., Muzzarelli, R.A., Muzzarelli, C. et al. (2004) Chitosan chemistry and pharmaceutical perspectives. Chem. Rev., 104, 6017-6084.
17. Qian, R.Q. and Glanville, R.W. (2004) Methods for purifying chitosan, Patent US 2004118778.
18. Butelman, F. (1990) Newprocess for preparing chitosan and its derivatives containing quaternary ammonium groups, Patent EP 0400364.
19. Sashiwa, H., Makimura, Y., Roy, R. and Shigemasa, Y. (2000) Chemical modification of chitosan: preparation of chitosan-sialic acid branched polysaccharide hybrids. Chem. Commun., 11, 909-910.
20. Sashima, H., Thompson, J.M., Das, S.K. et al. (2000) Chemical modification of chitosan: preparation and lectin binding properties of alpha-galactosyl-chitosan conjugates: potential inhibitors in acute rejection following xenotransplantation. Biomacromolecules, 1, 303-305.
21. Liu, W.G. and Yao, K.D. (2002) Chitosan and its derivatives-a promising non-viral vector for gene transfection. J. Control. Release, 83, 1-11.
22. Park, J.H., Cho, Y.W., Chung, H. et al. (2003) Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. Biomacromolecules, 4, 1087-1091.
23. Bernkop-Schnürch, A. (2004) Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Release, 94, 177-186.
24. Pillai, C.K.S., Paul, W. and Sharma, C.P. (2009) Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog. Polym. Sci., 34, 641-678.
25. Sashiwa, H. (2004) Chemically modified chitin and chitosan as biomaterials. Prog. Polym. Sci., 29, 887-908.
26. Meister,C. and Donges, R. (1990) Process for the preparation of activated chitosans and their use in the preparation of chitosan derivatives, Patent CA 2009384 (A1).
27. Lohmann, D. and Randell, D.R. (1993) N-substituted chitosane derivatives, process for preparing them and their use, Patent EP 0563013.
28. Kulbokaite, R., Ciuta, G., Netopilik, M. and Makuska, R. (2009) N-PEG'ylation of chitosan via "click chemistry" reactions. React. Funct. Polym., 69, 771-778.
29. Zhong, Z., Jianxin, W. and Wei, S. (2008) Method for synthesizing N,N,N-trimethyl chitosan sulfate methyl ammonium, Patent CN 101157735.
30. Sajomsang,W., Rungsardthong Ruktanonchai, U., Gonil, P. and Nuchuchua, O. (2009) Mucoadhesive property and biocompatibility of methylated N-aryl chitosan derivatives. Carbohydr. Polym., 78, 945-952.
31. Park, J.H., Saravanakumar, G., Kim, K. and Kwon, I.C. (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev., 62, 28-41.
32. Ugwoke, M.I., Agu, R.U., Verbeke, N. and Kinget, R. (2005) Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv. Drug Deliv. Rev., 57, 1640-1665.
33. Sadeghi, A.M., Dorkoosh, F.A., Avadi, M.R. et al. (2008) Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur. J. Pharm. Biopharm., 70, 270-278.
34. Lai, S.K.,Wang, Y.Y. and Hanes, J. (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev., 61, 158-171.
35. Lehr, C., Bouwstra, J.A., Schacht, E.H. and Junginger, H.E. (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., 78, 43-48.
36. Loth, F.D. (1997) Process for preparing alkyl derivatives of chitosan, Patent EP 0778286.
37. Felt, O., Furrer, P., Mayer, J.M. et al. (1999) Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm., 180, 185-193.
38. Thanou, M.,Verhoef, J.C. and Junginger, H.E. (2001) Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev., 50, S91-S101.
39. El-Kamel, A. (2002) Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSciTech, 4, 1-7.
40. Alpar, H.O., Somavarapu, S., Atuah, K.N. and Bramwell, V.W. (2005) Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev., 57, 411-430.
41. Sayin, B., Somavarapu, S., Li, X.W. et al. (2009) TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. Eur. J. Pharm. Sci., 38, 362-369.
42. Yanjing, K., Yan, S., Zhigang, Y. et al. (2009) Antibiotic film for vagina and cervix, Patent CN 201223630.
43. de la Fuente, M., Ravina, M., Paolicelli, P. et al. (2010) Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv. Drug Deliv. Rev., 62, 100-117.
44. Arora, P., Sharma, S. and Garg, S. (2002) Permeability issues in nasal drug delivery. Drug Discov. Today, 7, 967-975.
45. Zhang, X., Zhang, H., Wu, Z. et al. (2008) Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur. J. Pharm. Biopharm., 68, 526-534.
46. Illum, L., Farraj, N.F. and Davis, S.S. (1994) Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 11, 1186-1189.
47. Artursson, P., Lindmark, T., Davis, S.S. and Illum, L. (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (caco-2). Pharm. Res., 11, 1358-1361.
48. Alonso Fernandez, M.J., Janes, K. and Csaba, N. (2006) Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules, Patent WO 2006097558.
49. Colo, G.D., Zambito, Y., Burgalassi, S. et al. (2002) Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int. J. Pharm., 248, 115-122.
50. de Campos, A.M., Diebold, Y., Carvalho, E.L.S. et al. (2004) Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm. Res., 21, 803-810.
51. Enriquez de Salamanca, A., Diebold,Y., Calonge, M. et al. (2006) Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest. Ophthalmol. Vis. Sci., 47, 1416-1425.
52. Iwadare, Y. (1995) Artificial lacrima for ophthalmology, Patent JP 7223966.
53. Mohapatra, S. and Lee, D.-W. (2007) Controlled and sustained gene transfer mediated by thiol-modified polymers, Patent WO 2007086923.
54. Yen, S.-F. and Reed, K. (1995) Liquid ophthalmic sustained release delivery system, Patent WO 9522315.
55. Nichols, J. (1995) Viscoelastic solution of N,O-carboxymethyl chitosan for ophthalmic use, Patent EP 0665022.
56. Reed, K. and Yen, S.-F. (1997) Compositions including O-carboxyalkyl chitosan and methods of use in ophthalmics, Patent WO 9706782.
57. Gurny, R. and Felt, O. (2000) Aqueous ophthalmic formulations comprising chitosan, Patent WO 0030609.
58. Gurny, R. and Felt, O. (2001) Antibacterial aqueous ophthalmic formulations containing ofloxacin and chitosan, Patent EP 1157688.
59. Wong, M.P.-H., Sou, M., Yen, S.-F. et al. (2002) Ophthalmic compositions comprising chitosan and an active substance, in particular ketotifen, and use thereof for the treatment of ocular allergic conditions, Patent WO 02100376.
60. Knuth, M. and Mueller, A. (2009) Method for coating silicone hydrogels, Patent WO 2009092726.
61. Yen, H., Hsiao, J. and Lee, W. (2010) Cylindrical biodegradable, biocompatible scleral buckle band, Patent NZ 568603.
62. Muzzarelli, R.A.A. (2009) Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr. Polym., 76, 167-182.
63. Muzzarelli, R., Tarsi, R., Filippini, O. et al. (1990) Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother., 34, 2010-2023.
64. Kibune, K. (1991) Bathing agent, Patent JP 3246218.
65. Kazuno, S., Seki, S., Tanaka, Y. and Shibazaki, K. (1994) Collagen synthesis promoter, Patent JP 6279294.
66. Yoneto, K. and Yoshioka, S. (1991) Wound coating-protective material, Patent JP 3015475.
67. Hirayama, T. and Yamamoto, M. (1994) Porous film, its preparation and wound covering material consisting of the same, Patent JP 6205825.
68. Iida, T. (1992) Wound covering material, Patent JP 4312458.
69. Miyata, T., Kodaira, K., Higashijima, H. et al. (1992) Biomaterial comprising a composite material of a chitosan derivative and collagen derivative, Patent US 5116824.
70. Struszczyk, H. and Kivekaes, O. (1994) Wound protecting dressing, Patent WO 9406484.
71. Lorenz, D. and Lee, C. (1995) Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives, Patent US 5420197.
72. Qin, Y. and Gilding, K.D. (1996) Wound treatment composition, Patent WO 9613284.
73. Kaessmann, H.-J. and An Haak, K. (1997) Chitosan foil for wound sealing and process for its preparation, Patent US 5597581.
74. Cochrum, K., Parker, H. and Chiu, M. (1998) Fibrinogen/chitosan hemostatic agents, Patent US 5773033.
75. Nordquist, R., Chen, W., Carubelli, R. and Adams, R. (1998) Chitosan-derived biomaterials Patent US 5747475.
76. Son, Y.-S., Youn, Y.-H., Hong, S.-I. et al. (2000) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge, Patent WO 0016817.
77. Toit, L.C., Pillay, V., Choonara, Y.E. et al. (2007) Patenting of nanopharmaceuticals in drug delivery: no small issue. Recent Pat. Drug Deliv. Formul., 1, 131-142.
78. Yuan, X., Yang, X., Cai, D. et al. (2008) Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis. Vaccine, 26, 3727-3734.
79. Singh, R. and Lillard, J.W. Jr. (2009) Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 86, 215-223.
80. Alonso, M.J., Calvo, S.P., Remuñán-López, C. and Vila-Jato, J. (1997) Development of nanoparticles based on hydrophilic polymers, Patent ES 2098188.
81. Kropf, C. and Reil, S. (2001) Method for producing nanoparticulate chitosans or chitosan derivatives, Patent WO 0132751.
82. Chen, M.-C., Tu, H., Sung, H.-W. and Lin, Y.-H. (2008) Nanoparticles for drug delivery, Patent US 2008160078.
83. Lopez-Berestein, G., Ozturk, E., Sanguino, A. et al. (2011) Methods and compositions involving chitosan nanoparticles, Patent US 2011064664.
84. Fernandez, M.J., Remuñán-López, C., Cuna Vilan, M.M. and Alonso Sande, M. (2006) Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same, Patent US 2006134785.
85. Nah, J.-W., Jung, T.R., Chae, S.Y. et al. (2007) Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof, Patent WO 2007086651.
86. Zhang, J., Chen, X.G., Li,Y.Y. and Liu, C.S. (2007) Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine, 3, 258-265.
87. Dash, A. and Trickler, W. (2008) Mucoadhesive nanoparticles for cancer treatment, Patent WO 2008105852.
88. Kim, J.H., Kim, Y.S., Park, K. et al. (2008). Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J. Control. Release, 127, 41-49.
89. Jingjing, D., Sidong, L.,Weiyan, Q. et al. (2010) Preparation method of ribavirin-quaternized chitosan nanoparticles, Patent CN 101804031.
90. Csaba, N., Garcia-Fuentes, M. and Alonso, M.J. (2009) Nanoparticles for nasal vaccination. Adv. Drug Deliv. Rev., 61, 140-157.
91. Slutter, B., Plapied, L., Fievez, V. et al. (2009) Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J. Control. Release, 138, 113-121.
92. Badwan, A.A., AL-Remawi, M., EL-Taher, T. and Elsayed, A. (2007) Oral delivery of protein drugs using microemulsion, Patent WO 2007068311.
93. Sung, H.-W., Chen, M.-C., Lee, P.-W. and Tu, H. (2011) Nanoparticles for protein/peptide delivery and delivery means thereof, Patent US 7901711.
94. Jiping, C., Nan, Z., Fengqian, L. et al. (2010) Chitosan nanoparticle preparation for vascular endothelial growth factor monoclonal antibody Avastin, Patent CN 101623268.
95. Yangguan,W. (2011) Poly-porous hollow screw for target delivery of growth factors and stem cells: the design and potential clinical application, Patent US 2011093020.
96. Hagenaars, N., Verheul, R.J., Mooren, I. et al. (2009) Relationship between structure and adjuvanticity of N,N,Ntrimethyl chitosan (TMC) structural variants in a nasal influenza vaccine. J. Control. Release, 140, 126-133.
97. Illum, L. and Chatfield, S.N. (2002) Vaccine compositions including chitosan for intranasal administration and use thereof, Patent US 6391318.
98. Rossi, N., Kaeuper, P., McCullough, K.C. and Harwood, L. (2010) Compound, medicament, vaccine composition and nanocapsules, Patent WO 2010067318.
99. Fernandes, J., Winnik, F., Mansouri, S. and Yan, C. (2006) Folic acid-chitosan-DNA nanoparticles, Patent US 2006105049.
100. Alonso, F.M.J., Garcia Fuentes, M., Maestrelli, F. and Mura, P. (2006) Nanoparticles comprising chitosan and cyclodextrin, Patent WO 2006128937.
101. Bayat, A., Larijani, B., Ahmadian, S. et al. (2008) Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine, 4, 115-120.
102. Tiyaboonchai,W. (2003) Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ. J., 11, 51-66.
103. Agnihotri, S.A., Mallikarjuna, N.N. and Aminabhavi, T.M. (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release, 100, 5-28.
104. Park, M.O., Oh, Y.K., Noh, S.M. et al. (2008) A chitosan based polymer conjugate and a method for producing the same, Patent KR 100825519.
105. Howard, K.A., Kjems, J., Liu, X. and Besenbacher, F. (2011) Nanoparticles for nucleic acid delivery, Patent EP 2295045 (A1).
106. Hsu, E., Fleet, C., Cheung, A. and Gao, J. (2011) High concentration chitosan-nucleic acid polyplex compositions, Patent US 2011039917.
107. Mumper, R.J. and Rolland, A. (1997) Chitosan-related compositions and methods for delivery of nucleic acids into a cell, Patent WO 9742975 (A2).
108. Lai, W.F. and Lin, M.C. (2009) Nucleic acid delivery with chitosan and its derivatives. J. Control. Release, 134, 158-168.
109. Mao, S., Sun,W. and Kissel,T. (2010) Chitosan-based formulations for delivery ofDNAand siRNA. Adv. Drug Deliv. Rev., 62, 12-27.
110. Rudzinski,W.E. and Aminabhavi, T.M. (2010) Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm., 399, 1-11.
111. Noh, S.M., Park, M.O., Shim, G. et al. (2010) Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA. J. Control. Release, 145, 159-164.
112. Kiang, T., Wen, J., Lim, H.W. and Leong, K.W. (2004) The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials, 25, 5293-5301.
113. Kim, T.-H., Jiang, H.-L., Jere, D. et al. (2007) Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog. Polym. Sci., 32, 726-753.
114. de Martimprey, H., Vauthier, C., Malvy, C. and Couvreur, P. (2009) Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. Eur. J. Pharm. Biopharm., 71, 490-504.
115. Howard, K.A., Rahbek, U.L., Liu, X. et al. (2006)RNAinterference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther., 14, 476-484.
116. Ji, A.M., Su, D., Che, O. et al. (2009) Functional gene silencing mediated by chitosan/siRNA nanocomplexes. Nanotechnology, 20, 405-412.
117. Gary, D.J., Puri, N. and Won, Y.Y. (2007) Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J. Control. Release, 121, 64-73.
118. Gaspar, R. and Duncan, R. (2009) Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics. Adv. Drug Deliv. Rev., 61, 1220-1231.
119. Irène, B., Catherine, D. and Patrick, C. (2002) Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 54, 631-651.
120. Morrow, K.J. Jr., Bawa, R. and Wei, C. (2007) Recent advances in basic and clinical nanomedicine. Med. Clin. North. Am., 91, 805-843.
121. Meister, C. and Donges, R. (1990) Process for preparing activated chitosans and their use in the preparation of chitosan derivatives, Patent EP 0382150.
122. Franzoni, C., Gagnieu, C. and Porte, H. (1991) Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants, Patent US 5077052.
123. Barry, J.J., Higham, P.A. and Mann, N.N. (1993) Process for insolubilizing N-carboxyalkyl derivatives of chitosan, Patent WO 9313137.
124. Lohmann, D. and Randell, D.R. (1999) Crosslinked N-substituted chitosan derivatives, Patent US 5977330.
125. Sugimoto, M. and Shigemasa, Y. (1999) Chitosan derivatives and methods of manufacturing the same, Patent WO 9901479.
126. Kim, K.S. and Cho, S.H. (2000) Preparation method of quaternary ammonium group. n-substituted soluble chitosan derivatives, Patent KR 20000007055.
127. Rathjens, A. and Wachter, R. (2000) New N-substituted chitan and chitosan derivatives, useful as hydrocolloid in cosmetics and pharmaceuticals, with good solubility in basic and neutral media, Patent DE 19857546.
128. Hung,W.M., Bergbauer, K.L., Su, K.C. andWang, G. (2002)Water soluble, randomly substituted partial N-partial Oacetylated chitosan, preserving compositions containing chitosan, and processes for making thereof, Patent US 2002177577.
129. Lopez, M.A. (2005) Process for preparing chitosan derivatives, derivatives obtained, compositions comprising them and treatment method, Patent WO 2005070971.
130. Yoshii, F., Nagasawa, N., Kume, T. and Mitomo, H. (2005) Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure, Patent US 2005113773.
131. Freier, T. (2008) Processing of chitosan and chitosan derivatives, Patent US 2008254125.
132. Auzely-Velty,R. and Creuzet, C. (2009) Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivatives that can be used to functionalize chitosan, Patent WO 2009034130.
133. Chen, S.-Y., Liu, K.-H. and Liu, D.-M. (2010) Hollow sphere from amphiphilic chitosan derivatives and method of preparing amiphiphilic chitosan derivative complex for medical use, Patent US 2010098731.
134. Schmidt, R.J. (2003) Wound dressing materials comprising chemically modified polysaccharides, Patent WO 03080134.
135. Watt, P. (2004) Wound dressings for the treatment of wound infection, Patent WO 2004024196.
136. Horng, L.L. (2005) Skin adherent hydrogels, Patent WO 2005055924.
137. Ishihara, M.,Yura, H., Saito,Y. et al. (2005) Composition for medical use containing sugar chain-containing chitosan derivative and glycosaminoglycan, Patent WO 2005025538.
138. Bedard, R. (2008) Combination of inorganic hemostatic agents with other hemostatic agents, Patent WO 2008076598.
139. Haggard, W., Noel, S. and Bumgardner, J. (2010) Compositions and methods for delivering an agent to a wound, Patent WO 2010107794.
140. Pravata, L. (2010) Adhesive composition, Patent WO 2010142507.
141. Ginns, E. and Ostroff, G. (2007) Compositions and their uses for gene therapy of bone conditions, Patent WO 2007050643.
142. Kjems, J., Howard, K.A., Besenbacher, F. and Deleuran, B. (2009) Nanoparticle-mediated treatment for inflammatory diseases, Patent CA 2731399.
143. Kjems, J., Howard, K.A., Besenbacher, F. and Andersen, M.O. (2009) Dehydrated chitosan nanoparticles, PatentCA 2729923.
144. Artursson, A.S., Issa, M.M., Strand, S.P. andVarum, K.M. (2009) Oligonucleotide non-viral delivery systems, Patent KR 20090058562.
145. Mohapatra, S., Xu,W.,Kong, X. et al. (2009) Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases, Patent WO 2009073527.
146. Yoo, H.S. and Lee, J.I. (2009) A thermo-sensitive gene carrier and a preparing method thereof, Patent KR 20090042369.
147. Lee, S.Y., Kwon, I.C., Kim, K.M. et al. (2010) siRNAdelivery system using self-assembled polymeric nanoparticles, Patent WO 2010131907.
148. Roy, K., Ghosn, B. and Kasturi, S. (2010) Modified polysaccharide-based delivery of nucleic acids, Patent US 2010311654.
149. Howard, K.A., Kjems, J., Besenbacher, F. et al. (2010) Treatment of radiation-induced fibrosis, Patent WO 2010085959.
150. Xiudong, L., Xiaojun, M., Yan, Y. and Weiting, Y. (2010) Method for photochemical cross-linking cell adhesion peptides on chitosan hydroxyl, Patent CN 101747450.